Overview

Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.

You can see this table by scrolling horizontally.

Company name Kyowa Kirin Co., Ltd.
Establishment July 1, 1949
  • *
    On October 1, 2008, KYOWA HAKKO KOGYO CO., LTD. changed its name to Kyowa Hakko Kirin Co., Ltd. following merger with Kirin Pharma Company, Limited.
  • *
    The company name was changed to "Kyowa Kirin Co., Ltd." as of July 1, 2019.
Capital ¥26,745 million (As of December 31, 2024)
Number of employees 5,669 (Consolidated base, as of December 31, 2024)
Representative Director of the Board Chairman & Chief Executive Officer: Masashi Miyamoto
President & Chief Operating Officer: Abdul Mullick
Headquarters Otemachi Financial City Grand Cube, 1-9-2 Otemachi,
Chiyoda-ku, Tokyo 100-0004
TEL:+81-3-5205-7200
Main Business Research, development, manufacturing, marketing and import / export of pharmaceuticals
Parent Company Kirin Holdings Company, LimitedOpen in new window
Corporate Profile DownloadPDF file
History History of Kyowa Kirin